Skip to main content

Table 1 Patient characteristics

From: Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study

Age (years)

62 (22 to 79)

Sex

Male: 12, female: 8

Body mass index (kg/m2)

28 (21 to 40)

APACHE II (score)

21.5 (17 to 26)

Length of ICU admission prior to study day 1 (days)

3.0 (1 to 16)

Glycated haemoglobin (HbA1c)

 

  %

5.9 (5.3 to 9.1)

  mmol/mol

40.5 (34 to 76)

Calories delivered in previous 24 hours (kcal)

885 (0 to 1,680)

Feed tolerant (patients)

14

Blood glucose concentration (mmol/l)

 

  Peak fasting

9.5 (6.6 to 14.2)

  Peak post prandial

10.7 (7.9 to 17.9)

Medicationsa

 

  Catecholamines

10

   Noradrenalin

10

   Adrenalin

1

  Opiates

11

   Fentanyl

10

   Oxycodone

1

  Sedatives

16

   Propofol

14

   Midazolam

3

   Ketamine

1

   Dexmedetomidine

1

  Insulin

8

   Peak dose (units/hour)

5.5 (2.5 to 10.5)

   Dose in previous 24 hours (units)

42.4 (15.0 to 117.0)

  Corticosteroid

7

   Hydrocortisone dose (or equivalent) on study day (mg/day)

200 (50 to 1,000)

RASS sedation score

−4 (−2 to –5)

Body temperature (°C)

37.0 (31.7 to 38.5)

Diagnosis category

 

  Neurology

6

  Trauma

4

  Respiratory

3

  Sepsis

2

  Cardiovascular

2

  Other

3

  1. Data presented as median (range); n = 20. APACHE, Acute Physiology and Chronic Health Evaluation; RASS, Richmond Agitation Sedation Scale. aPatients were on multiple medications during the course of the study.